Delivery Systems for RNA Interference-Based Therapy and Their Applications Against Cancer
RNA interference technology discovered in 1990 won the Nobel Prize in 2006. The first approved drug in 2018 inspired us once again. The technology has many advantages, but how to deliver it effectively has become a bottleneck to clinical practice. Lipid, polymer and modification methods have been developed to deliver small interfering RNA to target cells or tissues. Numerous clinical trials have been carried out to apply RNA interference technology to the treatment of tumors. This review covers the history and mechanism of RNA interference and the development of various delivery systems. The current progress of clinical trials for RNA interferencebased therapies against cancer is summarized. Challenges and opportunities for clinical application of RNA interference are discussed emphatically.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Document Type: Review Article
Publication date: January 1, 2020
More about this publication?
- Science of Advanced Materials (SAM) is an interdisciplinary peer-reviewed journal consolidating research activities in all aspects of advanced materials in the fields of science, engineering and medicine into a single and unique reference source. SAM provides the means for materials scientists, chemists, physicists, biologists, engineers, ceramicists, metallurgists, theoreticians and technocrats to publish original research articles as reviews with author's photo and short biography, full research articles and communications of important new scientific and technological findings, encompassing the fundamental and applied research in all latest aspects of advanced materials.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Ingenta Connect is not responsible for the content or availability of external websites